Back to catalogue
№ 123 30 filings · 2021-07-29 → 2026-07-21

COMPASS GROUP PLC

CPG
Consumer Products and Services Share price $30.65 Market cap $52.1bn Overall fit 380 /1000

High-quality compounder at fair price with real downside protection but only tangential AI-receiver status and limited operating leverage in a variable-cost services business — right kind of quality, wrong shape for this mandate.

Fair value range $28.00–$34.00 Mid case · $52.7bn
Absolute upside +1.1% vs current market cap
Conviction 4/5 confidence in fair call
Supports the call
  • Consistent multi-year in-year guidance raises with clear growth algorithm
  • Clean disclosure and strong FCF conversion make forecasts reliable
  • Three valuation methodologies converge in the $28-34 range
Limits the call
  • AI-hyperscaler exposure is qualitative, not sized to a revenue line
  • Post-Vermaat European M&A integration is a new chapter at unproven scale
Methodology

Forward P/E cross-checked with EV/EBITDA and DCF

In one line · bull case

High-quality global foodservice compounder capturing first-time outsourcing (including at AI hyperscaler data centres) with consistent margin progression and reliable low-teens EPS growth.

In one line · biggest risk

A stall in Business & Industry return-to-office volumes combined with rising leverage from aggressive European M&A could break the compounding algorithm.

Drivers
AI beneficiary 25 /100
Foodservice at AI-hyperscaler data centres is called out but is a small indirect adjacency — value from AI capex flows to tech vendors, not the caterer.
Operating leverage 40 /100
Predominantly variable cost stack; empirical margin progression ~20bps p.a. — not a multiple-of-profit on revenue beat.
Earnings vs expectations 75 /100
Guidance raised in-year every year across FY22–FY26 window; consistent modest beats.
Growth momentum 70 /100
Organic growth accelerated to 7%+ sustained; net new in 4–5% range for 5 consecutive years.
Moat 72 /100
Global procurement scale, 96%+ client retention, sub-sectorised model — durable but execution-based rather than regulatory.
Earnings quality 75 /100
87–88% underlying FCF conversion is genuine; underlying-vs-statutory bridge dominated by amortisation of acquired intangibles.
Management quality 75 /100
Consistent delivery vs. algorithm, disciplined capital allocation, transparent disclosure.
Cyclicality 40 /100
Balanced portfolio: defensive Healthcare/Defence offsets more cyclical B&I and Sports & Leisure.
Leverage 45 /100
Net debt/EBITDA at 1.7x (H1 26) — outside 1.0–1.5x target after $2.4bn M&A YTD, but investment-grade A/A2 and strong FCF cover.

COMPASS GROUP PLC (CPG) — Investment Research Note

Executive summary

Compass Group is the world's largest contract food services company, providing outsourced foodservice and targeted support services across Business & Industry, Healthcare & Senior Living, Education, Sports & Leisure, and Defence, Offshore & Remote sectors in 25+ countries. Across the 5-year filing window the operating trajectory is a textbook post-pandemic compounder: from a COVID-hit FY21 (underlying op margin 4.5%) through steady recovery to FY25 underlying op profit of $3.34bn on 7.2% margin, with FY26 guidance raised in-year to >11% profit growth on ~7% organic revenue growth 2026-05-11 HY26, 2026-07-21 Q3. The single most important valuation point today: this is a very high-quality mid-to-high single-digit organic grower with 96% client retention and expanding AI-hyperscaler exposure via its Business & Industry sector, trading at ~21x forward earnings — a fair-not-cheap multiple that requires continued execution rather than a re-rating.

Fair value estimate

  • Fair value range: $28 – $34 per share, implied market cap $47,600m – $57,800m USD.
  • Methodology: primary is a forward-P/E multiple of 19–23x on FY26E underlying EPS of ~$1.47 (FY25: 131.9c growing at guided 11%+ 2025-11-25 FY25). Cross-checked with EV/EBITDA (~11–13x on FY26E EBITDA of ~$5.5bn) and a simple DCF assuming 7% organic growth fading to 3% terminal with 8% WACC.
  • Key assumptions: organic growth sustains 6–7% through FY28; underlying margin progresses ~20bps annually (management's stated algorithm); net debt/EBITDA normalises back to 1.4x post-Vermaat; effective tax rate 25.5%.
  • Current price $30.78 vs. midpoint $31, i.e., roughly at fair value.
  • Absolute return vs. midpoint fair value: approximately +0.7% upside to the midpoint; range implies -9% to +10%.

Sector context

Correctly classified as Consumer Products and Services (ICB Consumer Discretionary). CPG's quality profile is meaningfully above typical peers: it enjoys unmatched global scale, procurement leverage on $360bn+ addressable market with <15% share, industry-leading client retention, and consistent low-teens EPS growth. Listed peers: Sodexo (SW.PA), Aramark (ARMK.US), and to a lesser extent Elior (ELIOR.PA). CPG's underlying margin (~7%+ and rising) and ROCE (18%) are structurally superior; leverage (1.4x post-Vermaat 1.7x) is well managed.

Investment thesis (3 bullets)

  1. Structural first-time outsourcing tailwind in a fragmented $360bn market. ~75% of the market is still self-operated or served by regional players. Wins are running at $4.3bn LTM (+16% y/y), with ~50% from first-time outsourcing, and the Group has delivered net new business in the 4–5% range for five consecutive years — well above the pre-pandemic ~3% run-rate 2026-07-21 Q3, 2025-11-25 FY25.
  2. AI-hyperscaler adjacency in Business & Industry. Compass now explicitly calls out data-centre foodservice contracts as a growth driver: "we continue to support leading AI hyperscalers across the data centre ecosystem, providing food and support services across both construction and operational phases" — Business & Industry has become the fastest-growing sector at double-digit organic rates 2026-07-21 Q3, 2026-05-11 HY26.
  3. Compounding margin and capital-return machine. Consistent 20bps annual margin progression, 87–88% underlying FCF conversion, ~50% earnings payout ratio, and a proven M&A blueprint being replicated in Europe (Vermaat, Pro Care Management, Dupont Restauration, 4Service). Investment-grade balance sheet (S&P A, Moody's A2) supports both bolt-on growth and buybacks 2025-11-25 FY25.

Key risks (3 bullets)

  1. Cyclical Business & Industry exposure to return-to-office / hybrid work. B&I is now the largest and fastest-growing sector — but a stall in office attendance or a corporate cost-cutting cycle at tech clients would hit like-for-like volumes materially 2026-05-11 HY26 sector table.
  2. Rising leverage from aggressive M&A and integration risk. Net debt/EBITDA reached 1.7x at H1 26 (outside the 1.0–1.5x target range) following the $1.7bn Vermaat and $270m Pro Care acquisitions, with $2.4bn of net M&A YTD; a bolt-on approach in Europe replicating the North America playbook is unproven at scale 2026-05-11 HY26.
  3. Food and labour cost inflation squeezing pricing-cost gap. Filings repeatedly flag inflation and labour shortages as principal risks; while indexation clauses help, sustained inflation could erode margin progression, especially in Europe where operating margin (6.1%) is still well below North America (8.4%) 2026-05-11 HY26, principal risks.

Operating leverage

Modest, not the "long-tail" profile the mandate seeks. Compass is a labour-plus-food business, with the cost stack roughly: food (~29% of revenue), employee remuneration (~47%), commissions/fees (~4%), depreciation & amortisation (~4%), and other costs (~12%) 2026-05-11 HY26 note 3. Roughly 75–80% of the cost base scales with revenue. Above-unit overheads (~1–2% of revenue) provide the main leverage lever, which is what drives the observed ~20bps annual margin expansion. Management describes the growth algorithm as "mid-to-high single-digit organic revenue growth with ongoing margin progression, leading to profit growth ahead of revenue growth" — i.e., roughly 1.3–1.5x revenue-to-profit growth ratio, not the 2x+ that a true operating-leverage story delivers. A hypothetical 10–20% upside revenue surprise would likely translate to ~15–25% operating-profit surprise (+50bps at best), not a multiple of profit. No obvious fixed-cost inflection point exists.

Value-trap signals

None identified. Revenue growing, margins expanding, cash conversion strong, credit ratings solid A/A2 (recently upgraded from A3), dividend reinstated FY22 and growing double-digit (43.3c final FY25), leverage disciplined even after M&A. The only mild watch-item is goodwill of $9bn concentrated in UK CGU where a reasonably possible discount-rate change could materially reduce headroom 2025-11-25 FY25 note 7 — but this is a sensitivity disclosure, not an impairment risk.

Earnings vs. expectations

Across the disclosure window Compass has been a serial "meets and modestly beats" story:

  • FY22–FY23: guidance repeatedly raised through the year; FY22 organic growth guided at 20–25% at H1, raised to ~35% at Q3, delivered 37.5%.
  • FY24: guidance repeatedly raised from "high single-digit" underlying operating profit growth (at Q1) to "towards 13%" (Q1), to "above 15%" (Q3), delivering 16.4% constant-currency 2024-11-26 FY24.
  • FY25: guidance raised at H1 from "high single-digit" to c.10%, delivered 11.7% constant-currency 2025-11-25 FY25.
  • FY26: guidance raised at H1 26 from ~10% to >11% underlying operating profit growth; Q3 update reiterates 2026-05-11 HY26, 2026-07-21 Q3. Pattern: consistent modest beats and progressive in-year guidance raises across four financial years.

Conviction

4 — high. Anchoring the call: (i) exceptionally clean and consistent disclosure with well-explained non-GAAP reconciliations, (ii) a very predictable growth algorithm (net new 4–5%, price ~3%, volume ~1%, margin +20bps) that has been delivered for five consecutive years, and (iii) multiple valuation approaches (P/E, EV/EBITDA, DCF) all converge in the $28–34 range. Limiting factors: (i) the AI-hyperscaler angle is a story rather than a quantified revenue line, so we cannot easily size the upside case; and (ii) Europe integration (Vermaat scaled) is a new chapter and the M&A pipeline could accelerate leverage further.

Driver scoring context

  • AI-beneficiary (25): Foodservice for AI hyperscaler data centres is called out but is a small, indirect adjacency — the value flows to the tech companies, not Compass. Business & Industry is fastest-growing but it's still a per-employee food revenue line.
  • Operating leverage (40): Predominantly variable cost structure; ~20bps annual margin progression is the empirical evidence — not a "multiple of profit on a revenue beat" story.
  • Earnings surprise trend (75): Guidance raised in-year every year FY22–FY26.
  • Cyclicality (40): Diversified sector mix with defensive Healthcare/Defence balanced against cyclical B&I/Sports.
  • Moat (72): Genuine global scale in procurement, 96% client retention, sector-specialisation with sub-brands, network effects on supplier and route density.
  • Leverage (45): 1.7x net debt/EBITDA post-Vermaat; investment-grade credit, strong FCF, but currently outside stated 1.0–1.5x target.
  • Earnings quality (75): Underlying-to-statutory bridge dominated by amortisation of acquired intangibles (a real-but-non-cash item); FCF conversion 87–88% is genuinely strong.
  • Management quality (75): Consistent execution, disciplined capital allocation framework, transparent long-term algorithm.
  • Growth momentum (70): Accelerating and sustained above historical rate — organic 7%+, plus M&A contribution.

Overall score rationale

CPG is a genuine high-quality defensive compounder trading roughly at fair value. It has a real (if indirect) AI-adjacency via B&I data-centre contracts, but it is fundamentally NOT an AI-receiver in the picks-and-shovels sense — the value from AI capex flows to semi/networking/power/cooling players, not their catering provider. Operating leverage is limited (typical variable-cost services business). Downside protection is strong. Net: this is a legitimate "quality name at fair price" but the wrong shape for a "AI-receiver + long-tail operating leverage" mandate.

Filings consulted · 34

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-07-21Q3 Trading Update2026-07-21_9678390_q3-trading-update.md0.85
  2. 2026-05-11Half Year Results Announcement2026-05-11_9560432_half-year-results-announcement.md0.90
  3. 2026-02-10Sterling Equivalent OF Final Dividend2026-02-10_9424216_sterling-equivalent-of-final-dividend.md0.30
  4. 2026-02-05Result OF Agm2026-02-05_9412138_result-of-agm.md0.30
  5. 2026-02-05Q1 Trading Statement2026-02-05_9410025_q1-trading-statement.md0.85
  6. 2025-12-17Annual Report 2025 And Notice OF Agm 20262025-12-17_9303473_annual-report-2025-and-notice-of-agm-2026.md0.81
  7. 2025-11-25Full Year Results2025-11-25_9254576_full-year-results.md0.85
  8. 2025-07-22Q3 Trading Update2025-07-22_8990239_q3-trading-update.md0.55
  9. 2025-05-14Half Year Results Announcement2025-05-14_8876281_half-year-results-announcement.md0.58
  10. 2025-02-11Sterling Equivalent OF Final Dividend2025-02-11_8731906_sterling-equivalent-of-final-dividend.md0.20
  11. 2025-02-06Trading Statement2025-02-06_8724001_trading-statement.md0.55
  12. 2025-02-06Result OF Agm2025-02-06_8726031_result-of-agm.md0.20
  13. 2024-11-26Full Year Results2024-11-26_8572018_full-year-results.md0.65
  14. 2024-07-23Trading Statement2024-07-23_8324533_trading-statement.md0.55
  15. 2024-05-15Half Year Results Announcement2024-05-15_8197008_half-year-results-announcement.md0.41
  16. 2024-02-08Result OF Agm2024-02-08_8029600_result-of-agm.md0.14
  17. 2024-02-08Agm And Q1 Trading Update2024-02-08_8027568_agm-and-q1-trading-update.md0.38
  18. 2024-01-22Proposed Acquisition OF CH Amp CO2024-01-22_7999477_proposed-acquisition-of-ch-amp-co.md0.34
  19. 2023-12-18Annual Financial Report And Notice OF Agm2023-12-18_7948813_annual-financial-report-and-notice-of-agm.md0.14
  20. 2023-11-20Full Year Results2023-11-20_7890475_full-year-results.md0.45
  21. 2023-07-25Third Quarter Trading Update2023-07-25_7652280_third-quarter-trading-update.md0.38
  22. 2023-05-10Half Year Results2023-05-10_7519452_half-year-results.md0.23
  23. 2023-02-09Result OF Agm2023-02-09_7405775_result-of-agm.md0.07
  24. 2023-02-09Agm And Q1 Trading Update2023-02-09_7403967_agm-and-q1-trading-update.md0.21
  25. 2022-11-21Full Year Results Announcement2022-11-21_7418857_full-year-results-announcement.md0.25
  26. 2022-07-26Trading Statement2022-07-26_7136101_trading-statement.md0.21
  27. 2022-07-26Replacement Trading Statement2022-07-26_7136696_replacement-trading-statement.md0.21
  28. 2022-05-11Half Year Results2022-05-11_7243032_half-year-results.md0.23
  29. 2022-03-24Disposal2022-03-24_7051042_disposal.md0.19
  30. 2022-02-03Result OF Agm2022-02-03_6709451_result-of-agm.md0.07
  31. 2022-02-03Agm And Q1 Trading Update2022-02-03_6707734_agm-and-q1-trading-update.md0.21
  32. 2021-11-23Full Year Results Announcement2021-11-23_6837509_full-year-results-announcement.md0.25
  33. 2021-09-21Pre Close Trading Update2021-09-21_6512389_pre-close-trading-update.md0.21
  34. 2021-07-29Trading Statement2021-07-29_6783578_trading-statement.md0.21

This research note was authored by a large language model after reading 30 regulatory filings published between 2021-07-29 and 2026-07-21. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.